Artículos por temáticas

Neural computation for rehabilitation

Hu X, Wang Y, Zhao T, Gunduz A.

Biomed Res Int. 2014;2014:603985. doi: 10.1155/2014/603985. Epub 2014 Dec 28.

Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders

Bañuelos-Cabrera I, Valle-Dorado MG, Aldana BI, Orozco-Suárez SA, Rocha L.

Arch Med Res. 2014 Nov;45(8):677-86. doi: 10.1016/j.arcmed.2014.11.010. Epub 2014 Nov 20.

PATHOLOGY IMAGE OF THE MONTH. Autopsy Findings in an Adult with Down Syndrome

Connor EE, Darga A, McGoey RR.

J La State Med Soc. 2014 Nov-Dec;166(6):272-4. Epub 2014 Dec 15.

A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease

Rosenbloom MH, Barclay TR, Pyle M, Owens BL, Cagan AB, Anderson CP, Frey WH 2nd, Hanson LR.

CNS Drugs. 2014 Dec;28(12):1185-9. doi: 10.1007/s40263-014-0214-y.

Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?

Snyder PJ, Kahle-Wrobleski K, Brannan S, Miller DS, Schindler RJ, DeSanti S, Ryan JM, Morrison G, Grundman M, Chandler J, Caselli RJ, Isaac M, Bain L, Carrillo MC.

Alzheimers Dement. 2014 Nov;10(6):853-60. doi: 10.1016/j.jalz.2014.07.158. Epub 2014 Nov 15.

Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment

Alberici A, Benussi A, Premi E, Borroni B, Padovani A.

Curr Alzheimer Res. 2014;11(10):909-17. doi: 10.2174/1567205011666141107151606.

Right anterior insula: core region of hallucinations in cognitive neurodegenerative diseases

Blanc F, Noblet V, Philippi N, Cretin B, Foucher J, Armspach JP, Rousseau F; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2014 Dec 5;9(12):e114774. doi: 10.1371/journal.pone.0114774. eCollection 2014.

Epigenetic nutraceutical diets in Alzheimer's disease

Davinelli S, Calabrese V, Zella D, Scapagnini G.

J Nutr Health Aging. 2014 Nov;18(9):800-5. doi: 10.1007/s12603-014-0552-y.

Polymorphism of the OLR1 3'UTR potential microRNA binding site and risk of Alzheimer's disease: a meta-analysis

Kong Y, Wu JB, Wang X, Zhao JF, Song H, Yuan LD.

Genet Mol Res. 2014 Dec 4;13(4):10162-72. doi: 10.4238/2014.December.4.10.

Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism

Stancu IC, Vasconcelos B, Terwel D, Dewachter I.

Mol Neurodegener. 2014 Nov 18;9:51. doi: 10.1186/1750-1326-9-51.

[The research progress of metals correlated to Alzheimer's disease]

Geng G, Luo HM.

Yao Xue Xue Bao. 2014 Oct;49(10):1372-6.

Heat shock protein 70 in Alzheimer's disease

Lu RC, Tan MS, Wang H, Xie AM, Yu JT, Tan L.

Biomed Res Int. 2014;2014:435203. doi: 10.1155/2014/435203. Epub 2014 Nov 6.

Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors

Liu C, Cui G, Zhu M, Kang X, Guo H.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):8342-55. eCollection 2014.

Postoperative medical complications associated with anesthesia in older adults with dementia

Seitz DP, Gill SS, Bell CM, Austin PC, Gruneir A, Anderson GM, Rochon PA.

J Am Geriatr Soc. 2014 Nov;62(11):2102-9. doi: 10.1111/jgs.13106. Epub 2014 Nov 4.

The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's disease

Chiu S, Woodbury-Fariña MA, Shad MU, Husni M, Copen J, Bureau Y, Cernovsky Z, Hou JJ, Raheb H, Terpstra K, Sanchez V, Hategan A, Kaushal M, Campbell R.

Psychiatr Clin North Am. 2014 Dec;37(4):591-623. doi: 10.1016/j.psc.2014.09.001. Epub 2014 Nov 25.